Cargando…

Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease

BACKGROUND: Obstructive sleep apnea (OSA) has been reported to affect cardiometabolic diseases. However, whether such association is causal is still unknown. Here, we attempt to explore the effect of OSA on type 2 diabetes (T2D), nonalcoholic fatty liver disease (NAFLD) and coronary heart disease (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xiaoxu, Zhao, Lanqing, Cui, Xiangguo, Qi, Li, Chen, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949721/
https://www.ncbi.nlm.nih.gov/pubmed/36846222
http://dx.doi.org/10.3389/fpsyt.2023.1068756
_version_ 1784893007798992896
author Ding, Xiaoxu
Zhao, Lanqing
Cui, Xiangguo
Qi, Li
Chen, Yu
author_facet Ding, Xiaoxu
Zhao, Lanqing
Cui, Xiangguo
Qi, Li
Chen, Yu
author_sort Ding, Xiaoxu
collection PubMed
description BACKGROUND: Obstructive sleep apnea (OSA) has been reported to affect cardiometabolic diseases. However, whether such association is causal is still unknown. Here, we attempt to explore the effect of OSA on type 2 diabetes (T2D), nonalcoholic fatty liver disease (NAFLD) and coronary heart disease (CHD). METHODS: Genetic variants associated with OSA were requested from a published genome-wide association study (GWAS) and those qualified ones were selected as instrumental variables (IV). Then, the IV-outcome associations were acquired from T2D, NAFLD and CHD GWAS consortia separately. The Mendelian randomization (MR) was designed to estimate the associations of genetically-predicted OSA on T2D, NAFLD and CHD respectively, using the inverse-variance weighted (IVW) method. We applied the Bonferroni method to adjust the p-value. Besides, MR-Egger regression and weighted median methods were adopted as a supplement to IVW. The Cochran's Q value was used to evaluate heterogeneity and the MR-Egger intercept was utilized to assess horizontal pleiotropy, together with MR-PRESSO. The leave-one-out sensitivity analysis was carried out as well. RESULTS: No MR estimate reached the Bonferroni threshold (p < 0.017). Although the odds ratio of T2D was 3.58 (95% confidence interval (CI) [1.06, 12.11], IVW-p-value = 0.040) using 4 SNPs, such causal association turned insignificant after the removal of SNP rs9937053 located in FTO [OR = 1.30 [0.68, 2.50], IVW p = 0.432]. Besides, we did not find that the predisposition to OSA was associated with CHD [OR = 1.16 [0.70, 1.91], IVW p = 0.560] using 4 SNPs. CONCLUSION: This MR study reveals that genetic liability to OSA might not be associated with the risk of T2D after the removal of obesity-related instruments. Besides, no causal association was observed between NAFLD and CHD. Further studies should be carried out to verify our findings.
format Online
Article
Text
id pubmed-9949721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99497212023-02-24 Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease Ding, Xiaoxu Zhao, Lanqing Cui, Xiangguo Qi, Li Chen, Yu Front Psychiatry Psychiatry BACKGROUND: Obstructive sleep apnea (OSA) has been reported to affect cardiometabolic diseases. However, whether such association is causal is still unknown. Here, we attempt to explore the effect of OSA on type 2 diabetes (T2D), nonalcoholic fatty liver disease (NAFLD) and coronary heart disease (CHD). METHODS: Genetic variants associated with OSA were requested from a published genome-wide association study (GWAS) and those qualified ones were selected as instrumental variables (IV). Then, the IV-outcome associations were acquired from T2D, NAFLD and CHD GWAS consortia separately. The Mendelian randomization (MR) was designed to estimate the associations of genetically-predicted OSA on T2D, NAFLD and CHD respectively, using the inverse-variance weighted (IVW) method. We applied the Bonferroni method to adjust the p-value. Besides, MR-Egger regression and weighted median methods were adopted as a supplement to IVW. The Cochran's Q value was used to evaluate heterogeneity and the MR-Egger intercept was utilized to assess horizontal pleiotropy, together with MR-PRESSO. The leave-one-out sensitivity analysis was carried out as well. RESULTS: No MR estimate reached the Bonferroni threshold (p < 0.017). Although the odds ratio of T2D was 3.58 (95% confidence interval (CI) [1.06, 12.11], IVW-p-value = 0.040) using 4 SNPs, such causal association turned insignificant after the removal of SNP rs9937053 located in FTO [OR = 1.30 [0.68, 2.50], IVW p = 0.432]. Besides, we did not find that the predisposition to OSA was associated with CHD [OR = 1.16 [0.70, 1.91], IVW p = 0.560] using 4 SNPs. CONCLUSION: This MR study reveals that genetic liability to OSA might not be associated with the risk of T2D after the removal of obesity-related instruments. Besides, no causal association was observed between NAFLD and CHD. Further studies should be carried out to verify our findings. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9949721/ /pubmed/36846222 http://dx.doi.org/10.3389/fpsyt.2023.1068756 Text en Copyright © 2023 Ding, Zhao, Cui, Qi and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Ding, Xiaoxu
Zhao, Lanqing
Cui, Xiangguo
Qi, Li
Chen, Yu
Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
title Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
title_full Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
title_fullStr Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
title_full_unstemmed Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
title_short Mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
title_sort mendelian randomization reveals no associations of genetically-predicted obstructive sleep apnea with the risk of type 2 diabetes, nonalcoholic fatty liver disease, and coronary heart disease
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949721/
https://www.ncbi.nlm.nih.gov/pubmed/36846222
http://dx.doi.org/10.3389/fpsyt.2023.1068756
work_keys_str_mv AT dingxiaoxu mendelianrandomizationrevealsnoassociationsofgeneticallypredictedobstructivesleepapneawiththeriskoftype2diabetesnonalcoholicfattyliverdiseaseandcoronaryheartdisease
AT zhaolanqing mendelianrandomizationrevealsnoassociationsofgeneticallypredictedobstructivesleepapneawiththeriskoftype2diabetesnonalcoholicfattyliverdiseaseandcoronaryheartdisease
AT cuixiangguo mendelianrandomizationrevealsnoassociationsofgeneticallypredictedobstructivesleepapneawiththeriskoftype2diabetesnonalcoholicfattyliverdiseaseandcoronaryheartdisease
AT qili mendelianrandomizationrevealsnoassociationsofgeneticallypredictedobstructivesleepapneawiththeriskoftype2diabetesnonalcoholicfattyliverdiseaseandcoronaryheartdisease
AT chenyu mendelianrandomizationrevealsnoassociationsofgeneticallypredictedobstructivesleepapneawiththeriskoftype2diabetesnonalcoholicfattyliverdiseaseandcoronaryheartdisease